BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding '''RTA Report for Re-lodgement of Transfer Requests of Physical Shares for the period ended May 2026 .'.
BALAXI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Balaxi Pharmaceuticals has submitted to the exchange a routine report from its Registrar and Transfer Agent (RTA) covering re-lodgement of physical share transfer requests for the period ended May 2026. This is a standard compliance filing required under SEBI/LODR norms, tracking physical share certificates whose transfer paperwork was re-submitted within the permitted window. No financial details, rejection figures, or outstanding share counts have been disclosed in the headline. The filing is administrative in nature and does not indicate any change in the company's shareholding structure or capital base.
No material impact on shareholders or stock price expected. This is a routine regulatory disclosure and reflects normal housekeeping of legacy physical shareholdings.